Additionally, elevated somatostatin concentrations in type 1 diabetes have been shown to suppress glucagon secretion, with the administration of somatostatin antagonists showing promise in restoring glucagon secretion in animal models of type1 diabetes.28, 29, 30, 31, 32. This evidence concerns the gene SST and type 1 diabetes mellitus.